152 related articles for article (PubMed ID: 12619525)
1. [Schizophrenia: adverse effects of atypical neuroleptics].
Bettina Polk B
Med Monatsschr Pharm; 2003 Feb; 26(2):57-9. PubMed ID: 12619525
[No Abstract] [Full Text] [Related]
2. Safety profile of iloperidone: a pooled analysis of 6-week acute-phase pivotal trials.
Weiden PJ; Cutler AJ; Polymeropoulos MH; Wolfgang CD
J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S12-9. PubMed ID: 18334908
[TBL] [Abstract][Full Text] [Related]
3. Choosing between atypical antipsychotics: weighing the risks and benefits.
Bailey KP
Arch Psychiatr Nurs; 2002 Jun; 16(3 Suppl 1):S2-S11. PubMed ID: 12046019
[No Abstract] [Full Text] [Related]
4. [Risperidone use in child and adolescent psychiatric patients].
Chevreuil C; Reymann JM; Frémaux T; Polard E; Séveno T; Bentué-Ferrer D
Therapie; 2008; 63(5):359-75. PubMed ID: 19154706
[TBL] [Abstract][Full Text] [Related]
5. Prolactin response and extrapyramidal side effects during propranolol and neuroleptic drugs treatment in chronic schizophrenic patients.
Elizur A; Segal S; Yeret A; Ben-David M
Isr Ann Psychiatr Relat Discip; 1979 Dec; 17(4):318-27. PubMed ID: 44877
[No Abstract] [Full Text] [Related]
6. Iloperidone: a clinical overview.
Citrome L
J Clin Psychiatry; 2011; 72 Suppl 1():19-23. PubMed ID: 22217439
[TBL] [Abstract][Full Text] [Related]
7. The safety and tolerability of atypical antipsychotics in bipolar disorder.
Seemüller F; Forsthoff A; Dittmann S; Born C; Bernhard B; Severus WE; Grunze H
Expert Opin Drug Saf; 2005 Sep; 4(5):849-68. PubMed ID: 16111448
[TBL] [Abstract][Full Text] [Related]
8. Treatment challenges and safety considerations for antipsychotic use in children and adolescents with psychoses.
McConville BJ; Sorter MT
J Clin Psychiatry; 2004; 65 Suppl 6():20-9. PubMed ID: 15104523
[TBL] [Abstract][Full Text] [Related]
9. Atypical antipsychotics in the treatment of schizophrenia. Paper underrates patients' experience of extrapyramidal symptoms.
Kerwin R
BMJ; 2001 Apr; 322(7291):926-7; author reply 927-8. PubMed ID: 11302914
[No Abstract] [Full Text] [Related]
10. Biological perspectives. Metabolic syndrome: schizophrenia and atypical antipsychotics.
Keltner NL
Perspect Psychiatr Care; 2006 Aug; 42(3):204-7. PubMed ID: 16916424
[No Abstract] [Full Text] [Related]
11. [Neuroleptics and the extrapyramidal system].
Haase HJ
Arzneimittelforschung; 1978; 28(9):1536-7. PubMed ID: 38814
[No Abstract] [Full Text] [Related]
12. Abnormalities of glucose metabolism associated with atypical antipsychotic drugs.
Newcomer JW
J Clin Psychiatry; 2004; 65 Suppl 18():36-46. PubMed ID: 15600383
[TBL] [Abstract][Full Text] [Related]
13. Atypical antipsychotics in the treatment of schizophrenia. Users' views are important.
Anderson I
BMJ; 2001 Apr; 322(7291):926; author reply 927-8. PubMed ID: 11302919
[No Abstract] [Full Text] [Related]
14. Sertindole: new drug. Another "atypical" neuroleptic; QT prolongation.
Prescrire Int; 2007 Apr; 16(88):59-62. PubMed ID: 17458045
[TBL] [Abstract][Full Text] [Related]
15. [Fewer adverse effects! Treatment with atypical neuroleptics].
Müller N; Riedel M
Pharm Unserer Zeit; 2002; 31(6):558-65. PubMed ID: 12481513
[No Abstract] [Full Text] [Related]
16. Health monitoring for patients who have schizophrenia. Summary of the Mount Sinai Conference recommendations.
Covell NH; Jackson CT; Weissman EM
Postgrad Med; 2006 Sep; Spec No():20-6. PubMed ID: 17128658
[TBL] [Abstract][Full Text] [Related]
17. Unwanted effects of psychotrophic drugs. II.--Drugs for schizophrenia.
Edwards JG
Practitioner; 1977 May; 218(1307):696-700. PubMed ID: 18729
[No Abstract] [Full Text] [Related]
18. Psychotic and Bipolar Disorders: Antipsychotic Drugs.
Holder SD; Edmunds AL; Morgan S
FP Essent; 2017 Apr; 455():23-29. PubMed ID: 28437058
[TBL] [Abstract][Full Text] [Related]
19. Switching in the era of atypical antipsychotics. An updated review.
Weiden PJ
Postgrad Med; 2006 Sep; Spec No():27-44. PubMed ID: 17128659
[TBL] [Abstract][Full Text] [Related]
20. [Atypical antipsychotic-induced weight gain].
Godlewska BR; Olajossy-Hilkesberger L; Marmurowska-Michałowska H; Olajossy M; Landowski J
Psychiatr Pol; 2006; 40(5):995-1007. PubMed ID: 17217241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
